Fort, L.P. Corcept Therapeutics Inc Transaction History

Fort, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$19.97 - $24.43 $260,928 - $319,202	-13,066 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$23.49 - $30.56 $36,973 - $48,101	1,574 Added 13.7%	13,066 $311,000
Q4 2020 Feb 12, 2021	BUY	$16.78 - $27.3 $11,829 - $19,246	705 Added 6.54%	11,492 $301,000
Q3 2020 Nov 13, 2020	BUY	$12.46 - $19.98 $134,406 - $215,524	10,787 New	10,787 $188,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

Stay updated on Fort, L.P. with notifications on news.